Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem

Therapeutic Advances in Drug Safety

Volumn 5, Issue 6, 2014, Pages 229-241

  Llor, Carl ^a   Bjerrum, Lars ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antibiotic resistance; point of care tests; primary care; rational use of antibiotics; strategies

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CLAVULANIC ACID; NON PRESCRIPTION DRUG;

ADVERSE OUTCOME; ALLERGIC REACTION; ANTIBIOTIC OVERUSE; ANTIBIOTIC RESISTANCE; ANTIGEN DETECTION; COMMUNICATION SKILL; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG USE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTITIONER; GOVERNMENT REGULATION; HEALTH CARE COST; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INAPPROPRIATE PRESCRIBING; INFECTION RISK; LIVER TOXICITY; MEDICAL AUDIT; MEDICALIZATION; MENTAL DISEASE; MORTALITY; NAUSEA; NEUROLOGIC DISEASE; OUTCOMES RESEARCH; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT REATTENDANCE; POINT OF CARE TESTING; PRIMARY MEDICAL CARE; RAPID TEST; RASH; RESPIRATORY TRACT INFECTION; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SELF MEDICATION; SOCIOECONOMICS; THERAPY DELAY; VIRUS INFECTION;

EID: 84911134714     PISSN: 20420986     EISSN: 20420994     Source Type: Journal    
DOI: 10.1177/2042098614554919     Document Type: Review

References (100)

1. Altiner A. Brockmann S. Sielk M. Wilm S. Wegscheider K. Abholz H. (2007) Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: A cluster-randomized intervention study. J Antimicrob Chemother 60: 638–644.
2. Arnold S. Straus S. (2005) Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 4: CD003539.
3. Ashworth M. Charlton J. Ballard K. Latinovic R. Gulliford M. (2005) Variations in antibiotic prescribing and consultation rates for acute respiratory infection in UK practices 1995–2000. Br J Gen Pract 55: 603–608.
4. Ayanruoh S. Waseem M. Quee F. Humphrey A. Reynolds T. (2009) Impact of rapid streptococcal test on antibiotic use in a pediatric emergency department. Pediatr Emerg Care 25: 748–750.
5. Bergman M. Huikko S. Pihlajamäki M. Laippala P. Palva E. Huovinen P. (2004) Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997–2001. Clin Infect Dis 38: 1251–1256.
6. Bjerrum L. Gahrn-Hansen B. Munck A. (2004) C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis. Br J Gen Pract 54: 659–662.
7. Bjerrum L. Munck A. Gahrn-Hansen B. Hansen M. Jarbol D. Cordoba G. (2011) Health Alliance for prudent antibiotic prescribing in patients with respiratory tract infections (HAPPY AUDIT) -impact of a non-randomised multifaceted intervention programme. BMC Fam Pract 12: 52.
8. Borg M. Sciclunca E. (2002) Over-the-counter acquisition of antibiotics in the Maltese general population. Int J Antimicrob Agents 20: 253–257.
9. Boucher H. Talbot G. Benjamin D. Jr Bradley J. Guidos R. Jones R. (2013) 10 × ′20 progress–development of new drugs active against Gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis 56: 1685–1694.
10. Butler C. Rollnick S. Pill R. Maggs-Rapport F. Stott N. (1998) Understanding the culture of prescribing: qualitative study of general practitioners– and patients– perceptions of antibiotics for sore throats. BMJ 317: 637–642.
11. Butler C. Simpson S. Dunstan F. Rollnick S. Cohen D. Gillespie D. (2012) Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. BMJ 344: d8173.
12. Cals J.W. Scheppers N.A. Hopstaken R.M. Hood K. Dinant G.J. Goettsch H. (2007) Evidence based management of acute bronchitis; sustained competence of enhanced communication skills acquisition in general practice. Patient Educ Couns 68: 270–278.
13. Cals J. Butler C. Hopstaken R. Hood K. Severens J. Dinant G. (2009) Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 338: b1374.
14. Cals J. de Bock L. Beckers P. Francis N. Hopstaken R. Hood K. (2013) Enhanced communication skills and C-reactive protein point-of-care testing for respiratory tract infection: 3.5-year follow-up of a cluster randomized trial. Ann Fam Med 11: 157–164.
15. Cals J. Schot M. de Jong S. Dinant G. Hopstaken R. (2010) Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med 8: 124–133.
16. Cals J. van Weert H. (2013) Point-of-care tests in general practice: hope or hype? Eur J Gen Pract 19: 251–256.
17. Carrasco-Garrido P. Jiménez-García R. Barrera V. Gil de Miguel A. (2008) Predictive factors of self-medicated drug use among the Spanish adult population. Pharmacoepidemiol Drug Saf 17: 193–199.
18. Centers for Disease Control and Prevention (2012) Diseases/pathogens associated with antimicrobial resistance. Available at: http://www.cdc.gov/drugresistance/DiseasesConnectedAR.html (Accessed: 24 August 2014).
19. Chang C. Schiano T. (2007) Review article: drug hepatotoxicity. Aliment Pharmacol Ther 25: 1135–1151.
20. Chen L. Chopra T. Kaye K. (2009) Pathogens resistant to antibacterial agents. Infect Dis Clin North Am 23: 817–845.
21. Coenen S. Francis N. Kelly M. Hood K. Nuttall J. Little P. (2013) Are patient views about antibiotics related to clinician perceptions, management and outcome? A multi-country study in outpatients with acute cough. PLoS One 8: e76691.
22. Cole A. (2014) GPs feel pressurised to prescribe unnecessary antibiotics, survey finds. BMJ 349: g5238.
23. Costelloe C. Metcalfe C. Lovering A. Mant D. Hay A. (2010) Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis. BMJ 340: c2096.
24. Davies S. Grant J. Catchpole M. (2013) The drugs don–t work. A Global Threat. London: Penguin Specials.
25. Department of Health (2012) Chief Medical Officer Annual Report 2011: Volume 2. Available at: http://www.gov.uk/government/publications/chief-medical-officer-annual-report-volume-2 (Accessed: 24 August 2014).
26. Deschepper R. Vander Stichele R. (2001) Differences in use of antibiotics in Europe: the role of cultural aspects. Pharm Weekbl 136: 794–797.
27. Dingle T. Abbott A. Fang F. (2014) Reflexive culture in adolescents and adults with group A streptococcal pharyngitis. Clin Infect Dis 59: 643–650.
28. Ebell M.H. Lundgren J. Youngpairoj S. (2013) How long does a cough last? Comparing patients– expectations with data from a systematic review of the literature. Ann Fam Med 11: 5–13.
29. European Commission (2010) Eurobarometer 338. Antimicrobial resistance. Survey carried out by TNS Opinion & Social at the request of the Directorate-General for Health and Consumers. Available at: http://ec.europa.eu/health/antimicrobial_resistance/docs/ebs_338_en.pdf (Accessed: 24 August 2014).
30. European Centre for Disease Prevention and Control (2010) Surveillance report. Surveillance of antimicrobial consumption in Europe. 2010. Available at: http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-antibiotic-consumption-ESAC-report-2010-data.pdf (Accessed: 24 August 2014).
31. European Centre for Disease Prevention and Control (2011) Antimicrobial resistance surveillance in Europe. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Available at: http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2011.pdf (Accessed: 24 August 2014).
32. European Centre for Disease Prevention and Control (2014) Key messages for primary care prescribers. Available at: http://ecdc.europa.eu/en/eaad/antibiotics/pages/messagesforprescribers.aspx (Accessed: 24 August 2014)
33. Falagas M. Rafailidis P. Matthaiou D. Virtzili S. Nikita D. Michalopoulos A. (2008) Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents 32: 450–454.
34. Flanders S. Stein J. Shochat G. Sellers K. Holland M. Maselli J. (2004) Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough. Am J Med 116: 529–535.
35. Francis N. Butler C. Hood K. Simpson S. Wood F. Nuttall J. (2009) Effect of using an interactive booklet about childhood respiratory tract infections in primary care consultations on reconsulting and antibiotic prescribing: A cluster-randomised controlled trial. BMJ 339: b2885.
36. Gonzales R. Anderer T. McCulloch C. Maselli J. Bloom F. Jr Graf T. (2013) A cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis. JAMA Intern Med 173: 267–273.
37. Goossens H. Ferech M. Vander Stichele R. Elseviers M. and ESAC Project Group. (2005) Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 365: 579–587.
38. Harbart S. Samore M. (2005) Antimicrobial resistance determinants and future control. Emerg Infect Dis 11: 794–801.
39. Hay A. Tilling K. (2014) Can 88% of patients with acute lower respiratory infection all be special? Br J Gen Pract 64: 60–62.
40. Ho J. Tambyah P. Paterson D. (2010) Multiresistant gram-negative infections: A global perspective. Curr Opin Infect Dis 23: 546–553.
41. Hollis A. Ahmed Z. (2013) Preserving antibiotics, rationally. N Engl J Med 369: 2474–2476.
42. Hopstaken R. Muris J. Knottnerus J. Kester A. Rinkens P. Dinant G. (2003) Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract 53: 358–364.
43. Høye S. Gjelstad S. Lindbæk M. (2013) Effects on antibiotic dispensing rates of interventions to promote delayed prescribing for respiratory tract infections in primary care. Br J Gen Pract 63: e777–e786.
44. Huang Y. Chen R. Wu T. Wei X. Guo A. (2013) Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies. Br J Gen Pract 63: e787–e794.
45. Hulscher M. Grol R. van der Meer J. (2010) Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 10: 167–175.
46. Humair J. Revaz S. Bovier P. Stalder H. (2006) Management of acute pharyngitis in adults: reliability of rapid streptococcal tests and clinical findings. Arch Intern Med 166: 640–644.
47. Huttner B. Goossens H. Verheij T. Harbarth S. (2010) Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis 10: 17–31.
48. Infectious Diseases Society of America, Spellberg B. Blaser M. Guidos R. Boucher H. Bradley J. (2011) Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 52(Suppl. 5): S397–S428.
49. Kenealy T. Arroll B. (2013) Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev 6: CD000247.
50. Kirby A. Herbert A. (2013) Correlations between income inequality and antimicrobial resistance. PLoS One 8: e73115.
51. Kollef M. (2008) Broad-spectrum antimicrobials and the treatment of serious bacterial infections: Getting it right up front. Clin Infect Dis 47: S3–S13.
52. Kumar S. Little P. Britten N. (2003) Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. BMJ 326: 138.
53. Laxminarayan R. Duse A. Wattal C. Zaidi A. Vertheim F. Sumpradit N. (2013) Antibiotic resistance – the need for global solutions. Lancet Infect Dis 13: 1057–1098.
54. Little P. Gould C. Williamson I. Warner G. Gantley M. Kinmonth A. (1997) Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ 315: 350–352.
55. Little P. Stuart B. Moore M. Coenen S. Butler C. Godycki-Cwirko M. (2013a) Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 13: 123–129.
56. Little P. Stuart B. Hobbs F. Butler C. Hay A. Campbell J. (2013b) Predictors of suppurative complications for acute sore throat in primary care: prospective clinical cohort study. BMJ 347: f6867.
57. Little P. Stuart B. Francis N. Douglas E. Tonkin-Crine S. Anthierens S. (2013c) Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial. Lancet 382: 1175–1182.
58. Little P. Moore M. Kelly J. Williamson I. Leydon G. McDermott L. (2014a) Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial. BMJ 348: g1606.
59. Little P. Stuart B. Hobbs F. Butler C. Hay A. Delaney B. (2014b) Antibiotic prescription strategies for acute sore throat: a prospective observational cohort study. Lancet Infect Dis 14: 213–219.
60. Livermore D. (2012) Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med 27: 128–142.
61. Llor C. Butler C. (2014) Better tests also in primary care. Clin Infect Dis 58: 1487–1488.
62. Llor C. Moragas A. Hernández S. Bayona C. Miravitlles M. (2012) Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186: 716–723.
63. Lode H. (2010) Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections. Am J Med 123 (4 Suppl.): S26–S38.
64. Maltezou H. Tasgris V. Antoniadou A. Gourgoulis G. Katerelos P. Adamis G. (2008) Evaluation of a rapid antigen detection test in the diagnosis of streptococcal pharyngitis in children and its impact on antibiotic prescription. J Antimicrob Chemother 62: 1407–1412.
65. McIsaac W. Kellner J. Aufricht P. Vanjaka A. Low D. (2004) Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA 291: 1587–1595.
66. McNulty C. Nichols T. French D. Joshi P. Butler C. (2013) Expectations for consultations and antibiotics for respiratory tract infection in primary care: the RTI clinical iceberg. Br J Gen Pract 63: e429–436.
67. Mölstad S. Erntell M. Hanberger H. Melander E. Norman C. Skoog G. (2008) Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 8: 125–132.
68. Moore M. McNulty C. (2012) European Antibiotic Awareness Day 2012: TARGET antibiotics through guidance, education, and tools. Br J Gen Pract 62: 621–622.
69. Moore M. Stuart B. Coenen S. Butler C. Goossens H. Verheij T. (2014) Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis of potential high-risk groups. Br J Gen Pract 64: e75–e80.
70. Morgan D. Okeke I. Laxminarayan R. Perencevich E. Weisenberg S. (2011) Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis 11: 692–701.
71. Nathwani D. Sneddon J. Patton A. Malcolm W. (2012) Antimicrobial stewardship in Scotland: impact of a national programme. Antimicrob Resist Infect Control 3: 7.
72. National Institute for Health and Clinical Excellence (2008) Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. London: National Institute for Health and Clinical Excellence. Respiratory tract infections – antibiotic prescribing. Guideline number 69.
73. Nordmann P. Cuzon G. Naas T. (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9: 228–236.
74. Oteo J. Pérez-Vázquez M. Campos J. (2010) Extended-spectrum beta-lactamase producing Escherichia coli: Changing epidemiology and clinical impact. Curr Opin Infect Dis 23: 320–326.
75. Oxford J. Kozlov R. (2013) Antibiotic resistance–a call to arms for primary healthcare providers. Int J Clin Pract Suppl 180: 1–3.
76. Paul M. Shani V. Muchtar E. Kariv G. Robenshtok E. Leibovici L. (2010) Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 54: 4851–4863.
77. Phillips T.G. Hickner J. (2005) Calling acute bronchitis a chest cold may improve patient satisfaction with appropriate antibiotic use. J Am Board Fam Pract 18: 459–463.
78. Plachouras D. Kavatha D. Antoniadou A. Giannitsioti E. Poulakou G. Kanellakopoulou K. (2010) Dispensing of antibiotics without prescription in Greece, 2008: another link in the antibiotic resistance chain. Eurosurveillance 15: 19488.
79. Public Health England (2012) Management of Infection Guidance for Primary Care for Consultation and Local Adaptation. November 2012, revised February 2013. Available at: http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/PrimaryCareGuidance/ (Accessed: 24 August 2014).
80. Riedel S. Beekmann S. Heilmann K. Richter S. Garcia-de-Lomas J. Ferech M. (2007) Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 26: 485–490.
81. Smith R. Coast J. (2013) The true cost of antimicrobial resistance. BMJ 346: f1493.
82. Smith S. Fahey T. Smucny J. Becker L. (2014) Antibiotics for acute bronchitis. Cochrane Database Syst Rev 3: CD000245.
83. Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society (2012) Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America, the Infectious Diseases Society of America, and the Pediatric Infectious Diseases Society. Infect Control Hosp Epidemiol 33: 322–327.
84. Spinks A. Glasziou P. Del Mar C. (2013) Antibiotics for sore throat. Cochrane Database Syst Rev 11: CD000023.
85. Spurling G. Del Mar C. Dooley L. Foxlee R. (2011) Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev 1: CD004417.
86. Steinman M. Ranji S. Shojania K. Gonzales R. (2006) Improving antibiotic selection: a systematic review and quantitative analysis of quality improvement strategies. Med Care 44: 617–628.
87. Tang H. Huang T. Jing J. Shen H. Cui W. (2009) Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection 37: 497–507.
88. Väänänen M. Pietilä K. Airaksinen M. (2006) Self-medication with antibiotics–does it really happen in Europe? Health Policy 77: 166–171.
89. van der Velden A. Duerden M. Bell J. Oxford J. Altiner A. Kozlov R. (2013) Prescriber and patient responsibilities in treatment of acute respiratory tract infections – Essential for conservation of antibiotics. Antibiotics 2: 316–327.
90. van der Velden A. Pijpers E. Kuyvenhoven M. Tonkin-Crine S. Little P. Verheij T. (2012) Effectiveness of physician-targeted interventions to improve antibiotic use for respiratory tract infections. Br J Gen Pract 62: e801–e807.
91. van Vugt S. Broekhuizen B. Lammens C. Zuithoff N. de Jong P. Coenen S. (2013) Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study. BMJ 346: f2450.
92. Venekamp R. Sanders S. Glasziou P. Del Mar C. Rovers M. (2013) Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 1: CD000219.
93. Versporten A. Bolokhovets G. Ghazaryan L. Abilova V. Pyshnik G. Spasojevic T. (2014) Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis. PII: S1473-3099(14)70071-4.
94. Williams M. (2008) Overuse of antibiotics for RTIs. Prescriber 19: 6–9.
95. World Health Organization (2009) Critically Important Antimicrobials for Human Medicine [2nd Revision]. Available at: http://www.who.int/foodsafety/foodbornedisease/CIA2ndrev2009.pdf (Accessed: 24 August 2014)
96. World Health Organization (2012a) Factsheet No: 194: Antimicrobial resistance. March 2012. Available at: http://www.Who.Int/mediacentre/factsheets/fs194/en/# (Accessed: 24 August 2014).
97. World Health Organization (2012b) The evolving threat of antimicrobial resistance–Options for action. Available at: http://www.who.int/patientsafety/implementation/amr/publication/en/ (Accessed: 24 August 2014).
98. World Health Organization (2013) Antimicrobial resistance. Fact sheet n°194. Updated May 2013. Available at: http://www.who.int/mediacentre/factsheets/fs194/en/
99. World Health Organization (2014) WHO–S first global report on antibiotic resistance reveals serious, worldwide threat to public health. Antimicrobial resistance – global surveillance report. Virtual Press Conference. 30 April 2014. Available at: http://www.who.int/mediacentre/multimedia/amr-transcript.pdf?ua=1 (Accessed: 24 August 2014).
100. Worrall G. Hutchinson J. Sherman G. Griffiths J. (2007) Diagnosing streptococcal sore throat in adults. Randomized controlled trial of in-office aids. Can Fam Physician 53: 667–671.